This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 19 and 80
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To examine variation rate of Non-HDL with KI1107 comparison Rosuvastatin monotherapy.

Provided treatments

  • Drug: KI1107 4 Capsules, QD
  • Drug: Rosuvastatin Calcium 20 MG, QD

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03026933. The sponsor of the trial is Kuhnil Pharmaceutical Co., Ltd. and it is looking for 215 volunteers for the current phase.
Official trial title:
A Multi-center, Randomized, Double Blind, Parallel Phase III Study to Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled